Grzegorz Mazur

Summary

Country: Poland

Publications

  1. ncbi IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma
    Grzegorz Mazur
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Pasteura 4, 50 367 Wroclaw, Poland
    Immunol Lett 96:241-6. 2005
  2. ncbi The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma
    Grzegorz Mazur
    Department of Internal, Occupational Diseases and Hypertension, Wroclaw Medical University, Poland
    Cytokine 64:422-6. 2013
  3. doi IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris
    Wojciech Baran
    Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
    Acta Derm Venereol 88:113-6. 2008
  4. pmc VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma
    Tomasz Wrobel
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
    Biomed Res Int 2013:159813. 2013
  5. pmc High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend?
    Julia Rudno-Rudzińska
    2nd Department of General and Oncological Surgery, Wroclaw Medical University, Borowska 213, 50 556, Wrocław, Poland
    Gastric Cancer 16:513-20. 2013
  6. ncbi IFN gamma gene polymorphism may contribute to the susceptibility to CLL
    Iwona Urbanowicz
    Department of Clinical Chemistry, Wroclaw Medical University, Pasteur 2 str, 50 367, Wroclaw, Poland
    Pathol Oncol Res 16:213-6. 2010
  7. ncbi IFN-gamma promoter gene polymorphism in psoriasis vulgaris
    Wojciech Baran
    Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
    Biomarkers 13:52-8. 2008
  8. ncbi Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes
    Tomasz Wróel
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wrocław, Poland
    Folia Histochem Cytobiol 44:43-7. 2006
  9. ncbi TGF-beta(1) gene polymorphism in psoriasis vulgaris
    Wojciech Baran
    Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Chalubinskiego 1, 50 368 Wroclaw, Poland
    Cytokine 38:8-11. 2007
  10. pmc VEGF and bFGF gene polymorphisms in Polish patients with B-CLL
    Tomasz Wrobel
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wybrzeze L Pasteura 4, 50 367 Wroclaw, Poland
    Med Oncol 30:456. 2013

Collaborators

Detail Information

Publications28

  1. ncbi IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma
    Grzegorz Mazur
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Pasteura 4, 50 367 Wroclaw, Poland
    Immunol Lett 96:241-6. 2005
    ..However, the IL-6 polymorphic features appeared as factors that might affect the survival of MM patients. The latter observation warrants further study...
  2. ncbi The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma
    Grzegorz Mazur
    Department of Internal, Occupational Diseases and Hypertension, Wroclaw Medical University, Poland
    Cytokine 64:422-6. 2013
    ..05). The impact of the CXCL12-3'A allele was confirmed by multivariate analyses. In conclusion, these results imply that the CXCL12-3'A allele plays a favourable role in patients with multiple myeloma...
  3. doi IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris
    Wojciech Baran
    Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
    Acta Derm Venereol 88:113-6. 2008
    ..No significant differences were found in the polymorphisms of IL-6 and IL-10 promoter genes between patients with psoriasis and healthy controls...
  4. pmc VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma
    Tomasz Wrobel
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
    Biomed Res Int 2013:159813. 2013
    ..37 versus 0.18, P = 0.095) and healthy individuals (0.37 versus 0.19, OR = 2.51, P = 0.038). These results imply that VEGF and bFGF gene polymorphisms have prognostic significance in patients with NHL. ..
  5. pmc High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend?
    Julia Rudno-Rudzińska
    2nd Department of General and Oncological Surgery, Wroclaw Medical University, Borowska 213, 50 556, Wrocław, Poland
    Gastric Cancer 16:513-20. 2013
    ..Even now, little is known about lymphangiogenesis in neoplastic tissue, and little is also known about the transmission of a neoplastic cell from the tumor mass into a lymphatic vessel...
  6. ncbi IFN gamma gene polymorphism may contribute to the susceptibility to CLL
    Iwona Urbanowicz
    Department of Clinical Chemistry, Wroclaw Medical University, Pasteur 2 str, 50 367, Wroclaw, Poland
    Pathol Oncol Res 16:213-6. 2010
    ..This results suggest that individuals rather prone to the lower level of IFN-gamma production (associated with the presence of the A allele) appear to be more susceptible to this malignant disease...
  7. ncbi IFN-gamma promoter gene polymorphism in psoriasis vulgaris
    Wojciech Baran
    Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
    Biomarkers 13:52-8. 2008
    ..The results suggest that IFN-gamma polymorphism is associated with susceptibility to psoriasis vulgaris...
  8. ncbi Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes
    Tomasz Wróel
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wrocław, Poland
    Folia Histochem Cytobiol 44:43-7. 2006
    ..NHL are not associated with increased expression of VEGF-C nor increased LYVE-1-positive lymphatic sinuses density within lymph nodes...
  9. ncbi TGF-beta(1) gene polymorphism in psoriasis vulgaris
    Wojciech Baran
    Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Chalubinskiego 1, 50 368 Wroclaw, Poland
    Cytokine 38:8-11. 2007
    ..TGF-beta(1) gene polymorphism in codon 10 and 25 is not associated with susceptibility to psoriasis vulgaris, but may be important for the type of the disease...
  10. pmc VEGF and bFGF gene polymorphisms in Polish patients with B-CLL
    Tomasz Wrobel
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wybrzeze L Pasteura 4, 50 367 Wroclaw, Poland
    Med Oncol 30:456. 2013
    ..These results suggest the possible association of the VEGF polymorphism with high risk B-CLL...
  11. ncbi Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma
    Grzegorz Mazur
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wrocław, Poland
    Folia Histochem Cytobiol 42:241-3. 2004
    ..Nevertheless, angiogenesis observed in nHL provides rationale for use of angiogenesis inhibitors in lymphoma therapy...
  12. ncbi TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients
    Grzegorz Mazur
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
    Cytokine 33:145-9. 2006
    ..302, p=0.057). TGF-beta1 gene polymorphisms were found to associate with the course of the disease in NHL patients. TGF-beta1 high producer genotype appeared as an independent risk factor of extranodal manifestation of the disease...
  13. doi Expression of cyclin A and bone morphogenetic protein receptors and response to induction therapy in patients with acute leukemias
    Justyna Dzietczenia
    Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
    Leuk Lymphoma 52:2336-41. 2011
    ..The expressions of BMPRIA, BMPRIB, BMPRII and cyclin A could be useful as prognostic parameters of the proliferation status of acute leukemia cells, but further studies are needed to assess this phenomenon...
  14. pmc Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor
    Grzegorz Mazur
    Dept of Internal and Occupational Diseases and Hypertension, Wroclaw Medical University, Wroclaw, Poland
    PLoS ONE 9:e98194. 2014
    ..Non-Hodgkin's lymphomas (NHL) constitute a heterogeneous group of lymphoproliferative diseases, which can localize not only to lymph nodes, but also can migrate to peripheral blood and metastase to other organs, including bone marrow...
  15. doi Heart rate variability and heart rate turbulence in patients with hematologic malignancies subjected to high-dose chemotherapy in the course of hematopoietic stem cell transplantation
    Małgorzata Poręba
    Department of Pathophysiology, Wroclaw Medical University, Wroclaw, Poland
    Ann Noninvasive Electrocardiol 19:157-65. 2014
    ..Noninvasive approaches allowing to evaluate an autonomic control of the heart function include analyses of both heart rate variability (HRV) and heart rate turbulence (HRT)...
  16. pmc High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients
    Aleksandra Butrym
    Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Pasteur 4 Str, 50 367 Wroclaw, Poland
    Med Oncol 30:560. 2013
    ..008). High expression of CD74 was positively correlated with more advanced stage of the disease (p = 0.02). No correlation was shown between CD74 and sex, mutational status IgVH and time to first treatment...
  17. doi High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients
    Aleksandra Butrym
    Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
    Leuk Res 36:876-80. 2012
    ..The aim of this study was to evaluate HS1 expression in CLL patients in connection with other known prognostic factors and patients' survival...
  18. ncbi Asymmetric dimethylarginine in hematological malignancies: a preliminary study
    Andrzej Szuba
    Department of Internal Medicine, Wroclaw Medical University, Poland
    Leuk Lymphoma 49:2316-20. 2008
    ..Elevated ADMA plasma levels in patients with hematological malignancies interfere with nitric oxide metabolism and may influence their prognosis. Further prognostic studies are postulated to assess this phenomenon...
  19. ncbi A - 308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients
    Wojciech Baran
    Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Ul Chalubinskiego 1, 50 368 Wroclaw, Poland
    Acta Dermatovenerol Alp Pannonica Adriat 15:113-8. 2006
    ..This study was performed to investigate the association between TNF-alpha single nucleotide polymorphism and susceptibility for psoriasis vulgaris...
  20. ncbi Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin's lymphoma
    Grzegorz Mazur
    Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Poland
    Folia Histochem Cytobiol 49:240-7. 2011
    ..In the cases of CCL2 and CCL3, expression in lymphomas was higher than in reactive lymph nodes. Patients with high expression of CCL2 and CXCL10 had shorter survival...
  21. doi Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20+ non-Hodgkin's lymphoma
    Justyna Dzietczenia
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Pasteura 4 Street, Wroclaw, 50 367, Poland
    Med Oncol 27:743-6. 2010
    ..Expression of CD55 and CD59 were higher in patients with bulky disease. In conclusion level of expression of CD46, CD55, and CD59 could be clinically helpful to predict the response to rituximab therapy...
  22. ncbi Elevated YB-1 expression is a new unfavorable prognostic factor in non-Hodgkin's lymphomas
    Katarzyna Szczuraszek
    Department of Histology and Embryology, Wroclaw Medical University, Wroclaw, Poland
    Anticancer Res 31:2963-70. 2011
    ..Y-Box-binding protein-1 (YB-1) acts as a transcription factor for multiple genes and is linked to DNA replication and repair, cell proliferation and resistance to cytostatic drugs...
  23. ncbi Expression of metallothionein (MT) and gluthatione s-transferase pi (SGTP) in the bone marrow of patients with myeloproliferative disorders (MPD)
    Tomasz Wrobel
    Department of Haematology, Blood Neoplasm and Bone Marrow Transplantation, Medical University, Wrocław, Poland
    Folia Morphol (Warsz) 63:129-31. 2004
    ..These data, although based on a relatively small number of patients, raise the possibility that SGTP and MT may play a role in the pathogenesis of MPD. The clinical significance of this phenomenon needs further investigation...
  24. doi Echocardiographic assessment of myocardial function in workers occupationally exposed to lead without clinically evident heart disease
    Rafał Poręba
    Department of Internal Medicine, Occupational Diseases and Hypertension, Wroclaw Medical University, Borowska 213, PL 50 556 Wroclaw, Poland
    Environ Toxicol Pharmacol 36:522-8. 2013
    ..The aim of the study was to evaluate echocardiographic changes in workers occupationally exposed to low doses of lead...
  25. ncbi Increased angiogenesis in cutaneous T-cell lymphomas
    Grzegorz Mazur
    Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw, Poland
    Pathol Oncol Res 10:34-6. 2004
    ..Increased MVD in the skin of CTCL patients indicate that angiogenesis may play a role in the growth of CTCL, and raises the possibility of using angiogenesis inhibitors in CTCL therapy...
  26. ncbi [Familial incidence of myelodysplastic syndromes]
    Tomasz Wrobel
    Z Kliniki Hematologii, Nowotworów Krwi i Transplantacji Szpiku Akademii Medycznej we Wrocławiu
    Wiad Lek 59:285-8. 2006
    ..There was absence of one mutagen common for every member of two reported families...
  27. ncbi [Amyloidosis in the course of multiple myeloma]
    Grzegorz Mazur
    Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku AM we Wrocławiu
    Pol Arch Med Wewn 113:341-5. 2005
    ..Among the multiple myeloma patients we found 17 with AL amyloid and 35 persons with elevated concentration of the serum SAA. The most frequent symptoms were related with renal failure and heart failure...
  28. ncbi [Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma]
    Lidia Usnarska-Zubkiewicz
    Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku AM we Wrocławiu
    Pol Arch Med Wewn 110:719-24. 2003
    ..In summary: serum level of VEGF in advanced state of multiple myeloma was elevated and correlated with clinical state. An elevated serum level of VEGF is associated with a poor prognosis...